218 related articles for article (PubMed ID: 2505852)
1. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils.
Remy E; Lenoir G; Houben A; Vandesteene C; Remacle J
Biochim Biophys Acta; 1989 Sep; 1005(1):87-92. PubMed ID: 2505852
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
3. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
Billah MM; Bryant RW; Siegel MI
J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982
[TBL] [Abstract][Full Text] [Related]
4. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
[TBL] [Abstract][Full Text] [Related]
5. An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells.
Suga K; Kawasaki T; Blank ML; Snyder F
J Biol Chem; 1990 Jul; 265(21):12363-71. PubMed ID: 2115518
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
[TBL] [Abstract][Full Text] [Related]
7. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
8. Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells.
Rosenthal MD; Franson RC
Biochim Biophys Acta; 1989 Dec; 1006(3):278-86. PubMed ID: 2557075
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.
Tessner TG; O'Flaherty JT; Wykle RL
J Biol Chem; 1989 Mar; 264(9):4794-9. PubMed ID: 2538461
[TBL] [Abstract][Full Text] [Related]
10. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
[TBL] [Abstract][Full Text] [Related]
11. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Shamsuddin M; Chen E; Anderson J; Smith LJ
J Lab Clin Med; 1997 Dec; 130(6):615-26. PubMed ID: 9422335
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis.
Reinhold SL; Zimmerman GA; Prescott SM; McIntyre TM
J Biol Chem; 1989 Dec; 264(36):21652-9. PubMed ID: 2513324
[TBL] [Abstract][Full Text] [Related]
13. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
Glaser KB; Lock YW; Chang JY
Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
15. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
16. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.
Cluzel M; Undem BJ; Chilton FH
J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414
[TBL] [Abstract][Full Text] [Related]
17. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases.
Baker PR; Owen JS; Nixon AB; Thomas L; Wooten R; Daniel LW; O'Flaherty JT; Wykle RL
Biochim Biophys Acta; 2002 Oct; 1592(2):175-84. PubMed ID: 12379481
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid release and platelet-activating factor formation by staurosporine in human neutrophils challenged with n-formyl peptide.
Müller S; Nigam S
Eur J Pharmacol; 1992 Aug; 218(2-3):251-8. PubMed ID: 1330596
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
McIntyre TM; Reinhold SL; Prescott SM; Zimmerman GA
J Biol Chem; 1987 Nov; 262(32):15370-6. PubMed ID: 2824456
[TBL] [Abstract][Full Text] [Related]
20. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
Sugiura T; Fukuda T; Masuzawa Y; Waku K
Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
